A citation-based method for searching scientific literature

Benjamin J Drapkin, Charles M Rudin. Cold Spring Harb Perspect Med 2021
Times Cited: 4







List of co-cited articles
45 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Nivolumab Monotherapy and Nivolumab Plus Ipilimumab in Recurrent Small Cell Lung Cancer: Results From the CheckMate 032 Randomized Cohort.
Neal E Ready, Patrick A Ott, Matthew D Hellmann, Jon Zugazagoitia, Christine L Hann, Filippo de Braud, Scott J Antonia, Paolo A Ascierto, Victor Moreno, Akin Atmaca,[...]. J Thorac Oncol 2020
83
75

Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1.
Lauren Averett Byers, Jing Wang, Monique B Nilsson, Junya Fujimoto, Pierre Saintigny, John Yordy, Uma Giri, Michael Peyton, You Hong Fan, Lixia Diao,[...]. Cancer Discov 2012
295
75

Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial.
Luis Paz-Ares, Mikhail Dvorkin, Yuanbin Chen, Niels Reinmuth, Katsuyuki Hotta, Dmytro Trukhin, Galina Statsenko, Maximilian J Hochmair, Mustafa Özgüroğlu, Jun Ho Ji,[...]. Lancet 2019
460
75

Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data.
Charles M Rudin, John T Poirier, Lauren Averett Byers, Caroline Dive, Afshin Dowlati, Julie George, John V Heymach, Jane E Johnson, Jonathan M Lehman, David MacPherson,[...]. Nat Rev Cancer 2019
227
75

Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis.
Eric E Gardner, Benjamin H Lok, Valentina E Schneeberger, Patrice Desmeules, Linde A Miles, Paige K Arnold, Andy Ni, Inna Khodos, Elisa de Stanchina, Thuyen Nguyen,[...]. Cancer Cell 2017
198
75

Pembrolizumab After Two or More Lines of Previous Therapy in Patients With Recurrent or Metastatic SCLC: Results From the KEYNOTE-028 and KEYNOTE-158 Studies.
Hyun Cheol Chung, Sarina A Piha-Paul, Jose Lopez-Martin, Jan H M Schellens, Steven Kao, Wilson H Miller, Jean-Pierre Delord, Bo Gao, David Planchard, Maya Gottfried,[...]. J Thorac Oncol 2020
93
75

First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer.
Leora Horn, Aaron S Mansfield, Aleksandra Szczęsna, Libor Havel, Maciej Krzakowski, Maximilian J Hochmair, Florian Huemer, György Losonczy, Melissa L Johnson, Makoto Nishio,[...]. N Engl J Med 2018
75

Comprehensive genomic profiles of small cell lung cancer.
Julie George, Jing Shan Lim, Se Jin Jang, Yupeng Cun, Luka Ozretić, Gu Kong, Frauke Leenders, Xin Lu, Lynnette Fernández-Cuesta, Graziella Bosco,[...]. Nature 2015
905
75

Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer.
C Allison Stewart, Pan Tong, Robert J Cardnell, Triparna Sen, Lerong Li, Carl M Gay, Fatemah Masrorpour, You Fan, Rasha O Bara, Ying Feng,[...]. Oncotarget 2017
91
75

Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial.
José Trigo, Vivek Subbiah, Benjamin Besse, Victor Moreno, Rafael López, María Angeles Sala, Solange Peters, Santiago Ponce, Cristian Fernández, Vicente Alfaro,[...]. Lancet Oncol 2020
71
75

Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer.
Triparna Sen, B Leticia Rodriguez, Limo Chen, Carminia M Della Corte, Naoto Morikawa, Junya Fujimoto, Sandra Cristea, Thuyen Nguyen, Lixia Diao, Lerong Li,[...]. Cancer Discov 2019
231
50

Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer.
C Allison Stewart, Carl M Gay, Yuanxin Xi, Santhosh Sivajothi, V Sivakamasundari, Junya Fujimoto, Mohan Bolisetty, Patrice M Hartsfield, Veerakumar Balasubramaniyan, Milind D Chalishazar,[...]. Nat Cancer 2020
49
50

Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III KEYNOTE-604 Study.
Charles M Rudin, Mark M Awad, Alejandro Navarro, Maya Gottfried, Solange Peters, Tibor Csőszi, Parneet K Cheema, Delvys Rodriguez-Abreu, Mirjana Wollner, James Chih-Hsin Yang,[...]. J Clin Oncol 2020
114
50

DNA methylation in small cell lung cancer defines distinct disease subtypes and correlates with high expression of EZH2.
J T Poirier, E E Gardner, N Connis, A L Moreira, E de Stanchina, C L Hann, C M Rudin. Oncogene 2015
125
50

POU2F3 is a master regulator of a tuft cell-like variant of small cell lung cancer.
Yu-Han Huang, Olaf Klingbeil, Xue-Yan He, Xiaoli S Wu, Gayatri Arun, Bin Lu, Tim D D Somerville, Joseph P Milazzo, John E Wilkinson, Osama E Demerdash,[...]. Genes Dev 2018
92
50

Nfib Promotes Metastasis through a Widespread Increase in Chromatin Accessibility.
Sarah K Denny, Dian Yang, Chen-Hua Chuang, Jennifer J Brady, Jing Shan Lim, Barbara M Grüner, Shin-Heng Chiou, Alicia N Schep, Jessika Baral, Cécile Hamard,[...]. Cell 2016
170
50

Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial.
Scott J Antonia, José A López-Martin, Johanna Bendell, Patrick A Ott, Matthew Taylor, Joseph Paul Eder, Dirk Jäger, M Catherine Pietanza, Dung T Le, Filippo de Braud,[...]. Lancet Oncol 2016
722
50

The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification.
William D Travis, Elisabeth Brambilla, Andrew G Nicholson, Yasushi Yatabe, John H M Austin, Mary Beth Beasley, Lucian R Chirieac, Sanja Dacic, Edwina Duhig, Douglas B Flieder,[...]. J Thorac Oncol 2015
50

Characterization of the cell of origin for small cell lung cancer.
Kwon-Sik Park, Mei-Chih Liang, David M Raiser, Raffaella Zamponi, Rebecca R Roach, Stephen J Curtis, Zandra Walton, Bethany E Schaffer, Caitlin M Roake, Anne-Flore Zmoos,[...]. Cell Cycle 2011
104
50

MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition.
Gurkan Mollaoglu, Matthew R Guthrie, Stefanie Böhm, Johannes Brägelmann, Ismail Can, Paul M Ballieu, Annika Marx, Julie George, Christine Heinen, Milind D Chalishazar,[...]. Cancer Cell 2017
200
50

Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancer.
Jing Shan Lim, Alvaro Ibaseta, Marcus M Fischer, Belinda Cancilla, Gilbert O'Young, Sandra Cristea, Vincent C Luca, Dian Yang, Nadine S Jahchan, Cécile Hamard,[...]. Nature 2017
161
50

Genomic and Functional Fidelity of Small Cell Lung Cancer Patient-Derived Xenografts.
Benjamin J Drapkin, Julie George, Camilla L Christensen, Mari Mino-Kenudson, Ruben Dries, Tilak Sundaresan, Sarah Phat, David T Myers, Jun Zhong, Peter Igo,[...]. Cancer Discov 2018
76
50

A framework for identification of actionable cancer genome dependencies in small cell lung cancer.
Martin L Sos, Felix Dietlein, Martin Peifer, Jakob Schöttle, Hyatt Balke-Want, Christian Müller, Mirjam Koker, André Richters, Stefanie Heynck, Florian Malchers,[...]. Proc Natl Acad Sci U S A 2012
117
50

The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer.
Eric Vallières, Frances A Shepherd, John Crowley, Paul Van Houtte, Pieter E Postmus, Desmond Carney, Kari Chansky, Zeba Shaikh, Peter Goldstraw. J Thorac Oncol 2009
324
50

The Combination of the PARP Inhibitor Olaparib and the WEE1 Inhibitor AZD1775 as a New Therapeutic Option for Small Cell Lung Cancer.
Alice Lallo, Kristopher K Frese, Christopher J Morrow, Robert Sloane, Sakshi Gulati, Maximillian W Schenk, Francesca Trapani, Nicole Simms, Melanie Galvin, Stewart Brown,[...]. Clin Cancer Res 2018
75
50

Crebbp Loss Drives Small Cell Lung Cancer and Increases Sensitivity to HDAC Inhibition.
Deshui Jia, Arnaud Augert, Dong-Wook Kim, Emily Eastwood, Nan Wu, Ali H Ibrahim, Kee-Beom Kim, Colin T Dunn, Smitha P S Pillai, Adi F Gazdar,[...]. Cancer Discov 2018
53
50

Lack of class II transactivator causes severe deficiency of HLA-DR expression in small cell lung cancer.
T Yazawa, H Kamma, M Fujiwara, M Matsui, H Horiguchi, H Satoh, M Fujimoto, K Yokoyama, T Ogata. J Pathol 1999
61
50

CHK1 Inhibition in Small-Cell Lung Cancer Produces Single-Agent Activity in Biomarker-Defined Disease Subsets and Combination Activity with Cisplatin or Olaparib.
Triparna Sen, Pan Tong, C Allison Stewart, Sandra Cristea, Aly Valliani, David S Shames, Abena B Redwood, You Hong Fan, Lerong Li, Bonnie S Glisson,[...]. Cancer Res 2017
98
50

Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for SCLC: Primary and Correlative Biomarker Analyses.
Taofeek K Owonikoko, Huifeng Niu, Kristiaan Nackaerts, Tibor Csoszi, Gyula Ostoros, Zsuzsanna Mark, Christina Baik, Anil Abraham Joy, Christos Chouaid, Jesus Corral Jaime,[...]. J Thorac Oncol 2020
33
50

Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer.
A Doyle, W J Martin, K Funa, A Gazdar, D Carney, S E Martin, I Linnoila, F Cuttitta, J Mulshine, P Bunn. J Exp Med 1985
371
50

MYC-Driven Small-Cell Lung Cancer is Metabolically Distinct and Vulnerable to Arginine Depletion.
Milind D Chalishazar, Sarah J Wait, Fang Huang, Abbie S Ireland, Anandaroop Mukhopadhyay, Younjee Lee, Sophia S Schuman, Matthew R Guthrie, Kristofer C Berrett, Jeffery M Vahrenkamp,[...]. Clin Cancer Res 2019
46
50

An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer.
Marian L Burr, Christina E Sparbier, Kah Lok Chan, Yih-Chih Chan, Ariena Kersbergen, Enid Y N Lam, Elizabeth Azidis-Yates, Dane Vassiliadis, Charles C Bell, Omer Gilan,[...]. Cancer Cell 2019
135
50

Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group.
A Aupérin, R Arriagada, J P Pignon, C Le Péchoux, A Gregor, R J Stephens, P E Kristjansen, B E Johnson, H Ueoka, H Wagner,[...]. N Engl J Med 1999
50

Immunotherapeutic approaches for small-cell lung cancer.
Wade T Iams, Jason Porter, Leora Horn. Nat Rev Clin Oncol 2020
67
50

Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer.
Charles M Rudin, Steffen Durinck, Eric W Stawiski, John T Poirier, Zora Modrusan, David S Shames, Emily A Bergbower, Yinghui Guan, James Shin, Joseph Guillory,[...]. Nat Genet 2012
634
50

Targeting NOTCH activation in small cell lung cancer through LSD1 inhibition.
Arnaud Augert, Emily Eastwood, Ali H Ibrahim, Nan Wu, Eli Grunblatt, Ryan Basom, Denny Liggitt, Keith D Eaton, Renato Martins, John T Poirier,[...]. Sci Signal 2019
58
50

Intertumoral Heterogeneity in SCLC Is Influenced by the Cell Type of Origin.
Dian Yang, Sarah K Denny, Peyton G Greenside, Andrea C Chaikovsky, Jennifer J Brady, Youcef Ouadah, Jeffrey M Granja, Nadine S Jahchan, Jing Shan Lim, Shirley Kwok,[...]. Cancer Discov 2018
56
50

SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization.
Marina K Baine, Min-Shu Hsieh, W Victoria Lai, Jacklynn V Egger, Achim A Jungbluth, Yahya Daneshbod, Amanda Beras, Rowanne Spencer, Jessica Lopardo, Francis Bodd,[...]. J Thorac Oncol 2020
33
50

Neuroendocrine subtypes of small cell lung cancer differ in terms of immune microenvironment and checkpoint molecule distribution.
David Dora, Christopher Rivard, Hui Yu, Paul Bunn, Kenichi Suda, Shengxiang Ren, Shivaun Lueke Pickard, Viktoria Laszlo, Tunde Harko, Zsolt Megyesfalvi,[...]. Mol Oncol 2020
10
50

Randomized Phase II Trial of Cisplatin and Etoposide in Combination With Veliparib or Placebo for Extensive-Stage Small-Cell Lung Cancer: ECOG-ACRIN 2511 Study.
Taofeek K Owonikoko, Suzanne E Dahlberg, Gabriel L Sica, Lynne I Wagner, James L Wade, Gordan Srkalovic, Bradley W Lash, Joseph W Leach, Ticiana B Leal, Charu Aggarwal,[...]. J Clin Oncol 2019
66
50

Future Options of Molecular-Targeted Therapy in Small Cell Lung Cancer.
Arik Bernard Schulze, Georg Evers, Andrea Kerkhoff, Michael Mohr, Christoph Schliemann, Wolfgang E Berdel, Lars Henning Schmidt. Cancers (Basel) 2019
35
50

Phase III study of oral compared with intravenous topotecan as second-line therapy in small-cell lung cancer.
John R Eckardt, Joachim von Pawel, Jean-Louis Pujol, Zsolt Papai, Elisabeth Quoix, Andrea Ardizzoni, Ruth Poulin, Alaknanda J Preston, Graham Dane, Graham Ross. J Clin Oncol 2007
208
50

Randomized phase II study of bevacizumab in combination with chemotherapy in previously untreated extensive-stage small-cell lung cancer: results from the SALUTE trial.
David R Spigel, Peter M Townley, David M Waterhouse, Liang Fang, Ibrahim Adiguzel, Jane E Huang, David A Karlin, Leonardo Faoro, Frank A Scappaticci, Mark A Socinski. J Clin Oncol 2011
136
50

Efficacy and Safety of Rovalpituzumab Tesirine in Third-Line and Beyond Patients with DLL3-Expressing, Relapsed/Refractory Small-Cell Lung Cancer: Results From the Phase II TRINITY Study.
Daniel Morgensztern, Benjamin Besse, Laurent Greillier, Rafael Santana-Davila, Neal Ready, Christine L Hann, Bonnie S Glisson, Anna F Farago, Afshin Dowlati, Charles M Rudin,[...]. Clin Cancer Res 2019
105
50

Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer.
M Catherine Pietanza, Saiama N Waqar, Lee M Krug, Afshin Dowlati, Christine L Hann, Alberto Chiappori, Taofeek K Owonikoko, Kaitlin M Woo, Robert J Cardnell, Junya Fujimoto,[...]. J Clin Oncol 2018
151
50

Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model.
Ralph Meuwissen, Sabine C Linn, R Ilona Linnoila, John Zevenhoven, Wolter J Mooi, Anton Berns. Cancer Cell 2003
359
25

Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer.
Matthew D Hellmann, Margaret K Callahan, Mark M Awad, Emiliano Calvo, Paolo A Ascierto, Akin Atmaca, Naiyer A Rizvi, Fred R Hirsch, Giovanni Selvaggi, Joseph D Szustakowski,[...]. Cancer Cell 2019
45
25


Identification of Circulating Tumor DNA for the Early Detection of Small-cell Lung Cancer.
Lynnette Fernandez-Cuesta, Sandra Perdomo, Patrice H Avogbe, Noemie Leblay, Tiffany M Delhomme, Valerie Gaborieau, Behnoush Abedi-Ardekani, Estelle Chanudet, Magali Olivier, David Zaridze,[...]. EBioMedicine 2016
107
25

Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial.
Toshiaki Takahashi, Takeharu Yamanaka, Takashi Seto, Hideyuki Harada, Hiroshi Nokihara, Hideo Saka, Makoto Nishio, Hiroyasu Kaneda, Koichi Takayama, Osamu Ishimoto,[...]. Lancet Oncol 2017
210
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.